...
首页> 外文期刊>Journal of drug delivery science and technology >Development and evaluation of glipizide floating tablet
【24h】

Development and evaluation of glipizide floating tablet

机译:格列吡嗪漂浮片的研制与评价

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this research was to develop a novel gastroretentive drug delivery system based on effervescent technology for controlled delivery of active agent. Glipizide, a poorly soluble drug has been used as a model drug and an attempt has been made to improve the solubility of drug by the incorporation of accelerating agents, such as dispersant, alkalizing agent in conjunction with hydrophilic swellable polymer such as hydroxypropylmethylcellulose and present it in the form of gastroretentive floating tablets, which are designed to provide the desired controlled and complete release of drug for a prolonged period of time. Floating tablets were prepared by direct compression method. Hydroxypropylmethylcellulose (HPMC K15M, HPMC K100M) and Carbopol 940P were incorporated for gelforming properties. Buoyancy was achieved by adding an effervescent mixture of sodium bicarbonate and anhydrous citric acid. The optimized formulation (F7) exhibited 98.60% drug release in 24 h, while the buoyancy lag time was 140 s. In vitro drug release kinetics were found to follow both the zero order and the Korsmeyer and Peppas equation. The release of glipizide from the formulations was found to be non-Fickian type. Evaluation of gastric retention using X-ray imaging studies were performed on rabbit to justify the increased gastric residence time of the dosage form in the stomach, based on the floating principle. Optimized formulation (F7) showed no significant change in physical appearance, drug content, total buoyancy time, or in vitro dissolution pattern after storage at 40 °C/75% relative humidity for 1 month.
机译:这项研究的目的是开发一种基于泡腾技术的新型胃滞留药物递送系统,以控制活性剂的递送。格列吡嗪(一种难溶药物)已被用作模型药物,并已尝试通过加入促进剂(例如分散剂,碱化剂)和亲水性可溶胀聚合物(例如羟丙基甲基纤维素)来改善药物的溶解度以胃滞留性漂浮片剂的形式存在,其被设计为在延长的时间段内提供所需的受控和完全的药物释放。漂浮片剂通过直接压片法制备。羟丙基甲基纤维素(HPMC K15M,HPMC K100M)和Carbopol 940P被掺入以形成凝胶。通过添加碳酸氢钠和无水柠檬酸的泡腾混合物来实现浮力。优化的配方(F7)在24小时内显示98.60%的药物释放,而浮力滞后时间为140 s。发现体外药物释放动力学遵循零级以及Korsmeyer和Peppas方程。发现格列吡嗪从制剂中的释放是非菲克式的。基于浮动原理,在兔子上进行了X射线成像研究,以评估胃retention留,以证明剂型在胃中增加的胃停留时间。优化配方(F7)在40°C / 75%相对湿度下存放1个月后,物理外观,药物含量,总浮力时间或体外溶出度没有明显变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号